Details of Drug-Drug Interaction
| Drug General Information (ID: DDIDMWO47J) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Thiabendazole | Drug Info | Oxtriphylline | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Antinematodal Agents | Bronchodilators | |||||||
| Structure | |||||||||
| Mechanism of Thiabendazole-Oxtriphylline Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Decreased metabolism (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Thiabendazole | Oxtriphylline | |||||||
| Mechanism | Inhibition metabolism of methylxanthine | Methylxanthine | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Pharmacokinetics | ||||||||
| Factor Description | Alters the metabolism of the drug, leading to changes in the plasma concentration of the drug and affecting the pharmacological effects. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Clinical monitoring of patient response and tolerance and serum theophylline levels is recommended. Patients should be advised to report any signs of theophylline toxicity including nausea, vomiting, diarrhea, headache, restlessness, insomnia, or irregular heartbeat to their physicians. The theophylline dosage may require reduction or alternatives agents could be considered during thiabenzole therapy. | ||||||||
